Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H26Cl2N2O |
Molecular Weight | 369.329 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 1 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC=C(Cl)C(Cl)=C3
InChI
InChIKey=VQLPLYSROCPWFF-QRWMCTBCSA-N
InChI=1S/C19H26Cl2N2O/c1-22(19(24)13-14-8-9-15(20)16(21)12-14)17-6-2-3-7-18(17)23-10-4-5-11-23/h8-9,12,17-18H,2-7,10-11,13H2,1H3/t17?,18-/m1/s1
Molecular Formula | C19H26Cl2N2O |
Molecular Weight | 369.329 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3007743Curator's Comment: description was created based on several sources, including
https://google.com/patents/DE2749950C2 | https://www.ncbi.nlm.nih.gov/pubmed/28116477 | https://www.ncbi.nlm.nih.gov/pubmed/26330078 | https://www.ncbi.nlm.nih.gov/pubmed/26303466
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3007743
Curator's Comment: description was created based on several sources, including
https://google.com/patents/DE2749950C2 | https://www.ncbi.nlm.nih.gov/pubmed/28116477 | https://www.ncbi.nlm.nih.gov/pubmed/26330078 | https://www.ncbi.nlm.nih.gov/pubmed/26303466
U-50488 is a drug which acts as a highly selective κ-opioid agonist, but without any μ-opioid antagonist effects. U-50488 has analgesic, diuretic and antitussive effects, and reverses the memory impairment produced by anticholinergic drugs.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL237 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26330078 |
2.7 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28116477
C57BL6 male mice were placed in the open field for 30 min prior to injection of vehicle (saline) or 5 mg/kg i.p. U50488 (Tocris). Two hours later, mice were transcardially perfused with 4% paraformaldehyde (PFA) and 0.1 M PBS. Brains were postfixed overnight in PBS with 4% PFA and then transferred to 20% sucrose in PBS with 4% PFA.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20696141
Flasks of T. brucei were seeded at 1 x 104 cells/ml and incubated in the presence of the U50,488 for 3 days. Flasks were set up in triplicate for each inhibitor at multiples of EC50 along with 3 control flasks with no inhibitor added. Pentamidine and U50,488 were added in DMSO in a volume of 0.1% of the culture. Eflornithine was dissolved directly in HMI9-T medium and sterilised by 0.22 mMfiltration before diluting into the cell culture.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:11:06 GMT 2023
by
admin
on
Fri Dec 15 18:11:06 GMT 2023
|
Record UNII |
39K8JHE8XN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
39K8JHE8XN
Created by
admin on Fri Dec 15 18:11:06 GMT 2023 , Edited by admin on Fri Dec 15 18:11:06 GMT 2023
|
PRIMARY | |||
|
67198-13-4
Created by
admin on Fri Dec 15 18:11:06 GMT 2023 , Edited by admin on Fri Dec 15 18:11:06 GMT 2023
|
PRIMARY | |||
|
73358
Created by
admin on Fri Dec 15 18:11:06 GMT 2023 , Edited by admin on Fri Dec 15 18:11:06 GMT 2023
|
PRIMARY | |||
|
68616
Created by
admin on Fri Dec 15 18:11:06 GMT 2023 , Edited by admin on Fri Dec 15 18:11:06 GMT 2023
|
PRIMARY | |||
|
U-50488
Created by
admin on Fri Dec 15 18:11:06 GMT 2023 , Edited by admin on Fri Dec 15 18:11:06 GMT 2023
|
PRIMARY | |||
|
DTXSID50849401
Created by
admin on Fri Dec 15 18:11:06 GMT 2023 , Edited by admin on Fri Dec 15 18:11:06 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->LIGAND |
BINDING
IC50
|
||
|
TARGET->LIGAND |
WEAK BINDER
BINDING
IC50
|
||
|
TARGET -> AGONIST |
Selective for the kappa receptor no mu activity.
BINDING
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|